Updated Dec. 3, 2012 at 5:26 p.m.
Andrew Witty (GSK photo)
Image 1 of 2 · Next Image…
Research Triangle Park, N.C. — GlaxoSmithKline lays out a big drug development agenda to investors and analysts - 14 drug candidates to pivotal clinical trial over next two years - including proposed a heart dug and a cancer vaccine.
GSK aims for 14 drug candidates in pivotal trials over next two years
Post a comment
Print this blog postE-mail blog post
Share
Andrew Witty (GSK photo)
Image 1 of 2 · Next Image…
Research Triangle Park, N.C. — GlaxoSmithKline lays out a big drug development agenda to investors and analysts - 14 drug candidates to pivotal clinical trial over next two years - including proposed a heart dug and a cancer vaccine.
WRAL Tech Wire any time: Twitter, Facebook
Copyright 2013 WRAL Tech Wire. All rights reserved.Log in or upgrade to view WRALTechWire Insider content
To access this premium content and other benefits, become a WRAL TechWire Insider. Daily, monthly, and annual memberships available.
Please Log In to add a comment.
Best of TechWire Insider
OUR INSIDERS
WRAL TechWire Editor
The Skinny
Durham's high-tech infrastructure, talent lure Virginia company- Lenovo acknowledges layoffs in Morrisville as part of shift to 'PC Plus' strategy
- Raleigh-based PRA International eyes public offering
- Will lightning strike again for veteran entrepreneur Brian Handly at StepLeader?
- Raleigh app developer StepLeader lands $4.4M in first fund raiser
- IBM opens Linux center in China, says it will work with Red Hat
- Red-hot Raleigh startup WedPics hauls in $1.1M in funding
- New Triangle venture capital firm slowly emerging from shadows
- Titans of tech seek to excite UNC, Duke grads about a future beyond themselves
- Triangle politician tries to accelerate crowdfunding; bill passes first hurdle